Weei/nesn Jimmy Fund Radio-telethon

Laurie H. Glimcher, MD, was named President and CEO of Dana-Farber CancerInstitute in 2016. She is also Director of the Dana-Farber/Harvard Cancer Center and the Richard and Susan Smith Professor of Medicine at Harvard Medical School. Previously, she was the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. Dr. Glimcher is a distinguished immunologist, widely renowned for her work in one of the most promising areas of cancer research. A trailblazer in cancer research, Dr. Glimcher's research identified keytranscriptional regulators of protective immunity and the origin of pathophysiologicimmune responses underlying autoimmune, infectious, and malignant diseases. Dr. Glimcher speaks nationally and internationally on cancer, immunology, skeletal biology, and translational medicine, and has contributed more than 350 scholarly articles and papers to medical literature. Aside from her research efforts, Dr. Glimcher has been a s